UCSF The Medical Management of AIDS and Key Infections 2024

UCSF The Medical Management of AIDS and Key Infections 2024

 Include: 33 videos + 28 pdfs, size: 22.1 GB

 Target Audience: infectious disease specialists

 Information:

This course provides the active, intermediate-to-advanced clinician with a comprehensive review of the science of HIV and key infections including Hepatitis, RSV and COVID, as well as an update on the application of appropriate therapies. For ambitious new clinicians who want a challenge, we still offer our New Clinicians Track (NCT). This track provides five additional lectures that cover antiretroviral therapy (ART) 101, basic HIV pharmacology, management of ART resistance, IRIS, and opportunistic infections. All course lecturers are leading clinicians and teachers who are dedicated to teaching in their areas of expertise.

Acute and Long COVID continue to amplify existing health disparities and contribute to the vulnerability of all of our patients, making the need for up-to-date information about HIV/AIDS, HCV, HBV, add RSV, COVID and other key infections essential for providing high quality care. Current treatment options for acute COVID and understanding the science and management of Long COVID will be addressed.

All lectures will be cased-based with at least 2-4 ARS questions per session. Question and answer time as well as faculty panels are weaved into each conference day. The panels are designed with ARS questions so that you can privately test your individual knowledge against the experts throughout the conference. Questions that arise in the Chat will be answered throughout each conference day by our enthusiastic faculty

EDUCATIONAL OBJECTIVES
An attendee completing this course will have improved skills and strategies to:

•  Diagnose, treat, and prevent important conditions in HIV medicine and HIV medicine subspecialties, for improved patient outcomes;
   Apply in practice the latest treatment guidelines and recommendations for the prevention of HIV transmission and the appropriate use of PEP, PrEP, and DoxyPEP;
   Apply new recommendations for initiating and timely switching of antiretroviral combinations, and the use of long-acting therapy in appropriate patients;
   Identify the new developments and apply treatment recommendations in HIV related GI, cardiac, psychiatric and dermatologic disease as well as addiction medicine;
   Apply new recommendations for the treatment of HCV, HBV, cirrhosis, MASH and MAFLD.
   Align practice patterns more with current evidence and guidelines for treating STI’s, and HIV.
   Apply in practice the recommendations for the prevention of RSV, H5N1, and COVID transmission and the updated treatment guidelines for RSV, H5N1, and COVID
   Apply new recommendations for appropriate treatment of acute COVID and Long COVID

 Topics:

• Day 1 Cases & Challenges with ART.mp4
  Day 1 Cases & Controversies in PEP, PrEP & DoxyPEP.mp4
  Day 1 Cases & Controversies in PEP, PrEP & DoxyPEP.pdf
  Day 1 Great Cases from the Bay.mp4
  Day 1 Great Cases from the Bay.pdf
  Day 1 HIV Neurology Cases.pdf
  Day 1 Introduction.mp4
  Day 1 Introduction.pdf
  Day 1 Introductory Remarks.mp4
  Day 1 NCTNew Clinicians Workshop ART101 Antiretroviral Therapy Initiation From Guidelines to Practice.mp4
  Day 1 NCTNew Clinicians Workshop ART101 Antiretroviral Therapy Initiation From Guidelines to Practice.pdf
  Day 1 Opportunities and Challenges in STI Prevention and Treatment.mp4
  Day 1 Opportunities and Challenges in STI Prevention and Treatment.pdf
  Day 1 Q&A Prevention Panel Q&A.mp4
  Day 1 Rapid Fire Derm for Primary Care.pdf
  Day 1 The Leading Edge of Prevention.mp4
  Day 1 The Leading Edge of Prevention.pdf
  Day 1 The Long and Short of Long-Acting Formulations.mp4
  Day 1 The Long and Short of Long-Acting Formulations.pdf
  Day 1 The State of the Art of ART.mp4
  Day 1 Ton Ten Issues in HIV Medicine.mp4
  Day 1 Top Ten Issues in HIV Medicine.pdf
  Day 1 What’s New about HIV Cure.mp4
  Day 1 What’s New about HIV Cure.pdf
  Day 2 Cases from the STI Clinic in 2024.mp4
  Day 2 ID Pearls for HIV Providers.pdf
  Day 2 Managing Long COVID- What’s New.mp4
  Day 2 Managing Long COVID- What’s New.pdf
  Day 2 Navigating Outpatient COVID-19 Treatment Options.mp4
  Day 2 Navigating Outpatient COVID-19 Treatment Options.pdf
  Day 2 NCT Cases from the Inpatient HIV Service- OI’s and IRIS.mp4
  Day 2 NCT Cases from the Inpatient HIV Service- OI’s and IRIS.pdf
  Day 2 NCTIntroduction to ARV Drug Resistance.mp4
  Day 2 Prevention of anal cancer in people with HIV- new guidelines in 2024.mp4
  Day 2 Prevention of anal cancer in people with HIV- new guidelines in 2024.pdf
  Day 2 Respiratory Panel.mp4
  Day 2 RSV Across The Life Span- what’s new.mp4
  Day 2 RSV Across The Life Span- what’s new.pdf
  Day 2 The Building Blocks of HIV Therapy.mp4
  Day 2 The Building Blocks of HIV Therapy.pdf
  Day 2 Updates on H5N1 Influenza.mp4
  Day 2 Updates on H5N1 Influenza.pdf
  Day 2 Weight Management- Cases from the Clinic.mp4
  Day 2 Weight Management- Cases from the Clinic.pdf
  Day 2 What’s New in Endocrinology in 2024.mp4
  Day 2 What’s New in Endocrinology in 2024.pdf
  Day 2 What’s New in Transgender Care.pdf
  Day 3 Case Based Psychiatry.mp4
  Day 3 Case Based Psychiatry.pdf
  Day 3 Cases in Addiction Medicine and Pain Management.mp4
  Day 3 Cases in Addiction Medicine and Pain Management.pdf
  Day 3 HIV-associated Pulmonary Disease Classic and Challenging Cases for the Clinician, 2024.pdf
  Day 3 Interactive Panel Psychiatry & Managing Substance Use and Pain.mp4
  Day 3 Introduction.mp4
  Day 3 Liver Panel with Q&A.mp4
  Day 3 Substance use trends in the US- What providers need to know.mp4
  Day 3 Substance use trends in the US- What providers need to know.pdf
  Day 3 The Heart of the Matter of Cardiology.pdf
  Day 3 Updates from the Hepatitis Clinic MASLD, MASH, and More.mp4
  Day 3 Updates on HBV from the HIV Clinic.mp4
  Day 3 Updates on HBV from the HIV Clinic.pdf